Salvage Cryotherapy in Recurrent Prostate Cancer (SCORE)

University of Colorado Denver (CU Denver)

Status: Terminated

Conditions: Recurrent Prostate Cancer

Treatments: Procedure: Cryoablation / Cryotherapy

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00824928

06-1040

Details and patient eligibility

About

To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term efficacy and safety of this procedure. Ultimately the data analysis will serve as a robust guidance instrument for improving upon the utilization of this procedure for the treatment of patients with recurrent (LRD) prostate cancer.

Enrollment: 60 patients

Sex: Male

Ages: 30 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Read & understand informed consent related to this study including consenting and HIPPA authorization
• Undergone salvage cryotherapy of the prostate for recurrent prostate cancer

Exclusion criteria

• Patients who underwent radical prostatectomy as their primary therapy or other significant surgery (except prostatic biopsy)
• Patients with clinically confirmed distant metastasis (unless deemed beneficial by the treating physician)
• Any previous major rectal surgery
• Clinically significant lower urinary tract or rectal anomalies
• Existing urethral, rectal, or bladder fistulae

Trial design

60 participants in 1 patient group

Observational

Description:

Patients with locally recurrent prostate cancer that have chosen salvage cryotherapy

Treatment:

Procedure: Cryoablation / Cryotherapy